Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Global trial to evaluate Kevzara® (sarilumab) as COVID-19 therapy initiated

europeanpharmaceuticalreviewMarch 31, 2020

Tag: Kevzara , COVID-19 , Clinical Trial

PharmaSources Customer Service